Loading…
Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase
Cultured human endothelial cells synthesize and secrete two types of plasminogen activator, tissue plasminogen activator (t-PA) and urokinase (u-PA). Previous work from this laboratory (Hajjar, K.A., Hamel, N. M., Harpel, P. C., and Nachman, R. L. (1987) J. Clin. Invest. 80, 1712-1719) has demonstra...
Saved in:
Published in: | The Journal of biological chemistry 1990-02, Vol.265 (5), p.2908-2916 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cultured human endothelial cells synthesize and secrete two types of plasminogen activator, tissue plasminogen activator (t-PA)
and urokinase (u-PA). Previous work from this laboratory (Hajjar, K.A., Hamel, N. M., Harpel, P. C., and Nachman, R. L. (1987)
J. Clin. Invest. 80, 1712-1719) has demonstrated dose-dependent, saturable, and high affinity binding of t-PA to two sites
associated with cultural endothelial cell monolayers. We now report that an isolated plasma membrane-enriched endothelial
cell fraction specifically binds 125I-t-PA at a single saturable site (Kd 9.1 nM; Bmax 3.1 pmol/mg membrane protein). Ligand
blotting experiments demonstrated that both single and double-chain t-PA specifically bound to a Mr 40,000 membrane protein
present in detergent extracts of isolated membranes, while high molecular weight, low molecular weight, and single-chain u-PA
associated with a Mr 48,000 protein. Both binding interactions were reversible and cell-specific and were inhibitable by pretreatment
of intact cells with nanomolar concentrations of trypsin. The relevant binding proteins were not found in subendothelial cell
matrix, failed to react with antibodies to plasminogen activator inhibitor type 1 and interacted with their respective ligands
in an active site-independent manner. The isolated t-PA binding site was resistant to reduction and preserved the capacity
for plasmin generation. In contrast, the isolated u-PA binding protein was sensitive to reduction, and did not maintain the
catalytic activity of the ligand on the blot. The results suggest that in addition to sharing a matrix-associated binding
site (plasminogen activator inhibitor type 1), both t-PA and u-PA have unique membrane binding sites which may regulate their
function. The results also provide further support for the hypothesis that plasminogen and t-PA can assemble on the endothelial
cell surface in a manner which enhances cell surface generation of plasmin. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1016/s0021-9258(19)39887-4 |